Natural history and familial characteristics of isolated left ventricular non-compaction

Ross T Murphy1, Rajesh Thaman, Juan Gimeno Blanes

  • 1The Heart Hospital, University College London, 16-18 Westmoreland Street, London W1G 8PH, UK.

European Heart Journal
|December 25, 2004
PubMed

Insights

Left Ventricular Non-compaction (LVNC) is a rare heart condition. This study found LVNC has a better prognosis than previously thought and identified familial incidence, with relatives showing related cardiac abnormalities.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Diagnostics

Background:

  • Left Ventricular Non-compaction (LVNC) is a rare congenital heart disorder characterized by excessive myocardial trabeculations.
  • Previous literature indicated a poor prognosis for adult LVNC, but familial and asymptomatic cases suggest a potential for a prolonged pre-clinical phase.

Purpose of the Study:

  • To investigate the prognosis of Left Ventricular Non-compaction (LVNC) in a cohort of adult patients.
  • To determine the familial incidence and spectrum of cardiac abnormalities in relatives of LVNC patients.

Main Methods:

  • A 10-year retrospective study of 45 LVNC patients diagnosed at a cardiomyopathy referral center.
  • Systematic echocardiographic screening of asymptomatic relatives of affected individuals.

Main Results:

  • The study cohort (mean age 37) frequently presented with dyspnea (62%), abnormal ECG (91%), and impaired systolic function (66%).
  • Mean survival was high (97% at 46 months), with a low rate of thromboembolic events (4%).
  • Familial screening revealed LVNC or related abnormalities in 25% of asymptomatic relatives.

Conclusions:

  • LVNC is associated with a better prognosis than previously reported in the literature.
  • Familial LVNC can present with a spectrum of cardiac findings, including features resembling dilated cardiomyopathy in relatives.
Abstract

Related Concept Videos

Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...